ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.94322
-0.17%
Brent Oil
83.855
0.27%
Bitcoin
58,936.51
-0.31%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) Noticias

XNCR Xencor Inc

23.63
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Xencor Inc XNCR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 23.63 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
23.63
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/4/202407:01BWXencor Appoints Bart Cornelissen as Chief Financial Officer
11/3/202414:47EDGAR2Form 144 - Report of proposed sale of securities
11/3/202414:45EDGAR2Form 144 - Report of proposed sale of securities
11/3/202414:40EDGAR2Form 144 - Report of proposed sale of securities
11/3/202414:40EDGAR2Form 144 - Report of proposed sale of securities
07/3/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:39EDGAR2Form 144 - Report of proposed sale of securities
06/3/202407:32EDGAR2Form 8-K - Current report
05/3/202415:48EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:34EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:27EDGAR2Form 144 - Report of proposed sale of securities
28/2/202415:01BWXencor to Present at Upcoming Investor Conferences
27/2/202415:05EDGAR2Form 8-K - Current report
27/2/202415:01BWXencor Reports Fourth Quarter and Full Year 2023 Financial..
20/2/202415:31BWXencor to Host Webcast to Review Fourth Quarter and Full..
16/2/202416:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202417:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:07EDGAR2Form 144 - Report of proposed sale of securities
03/1/202415:01BWXencor to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202407:01BWDane Leone Joins Xencor as Senior Vice President, Corporate..
29/12/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202314:28EDGAR2Form 144 - Report of proposed sale of securities
21/11/202315:01BWXencor to Present at the Piper Sandler 35th Annual..
15/11/202315:02EDGAR2Form 8-K - Current report
07/11/202315:04EDGAR2Form 8-K - Current report
07/11/202315:03EDGAR2Form 8-K - Current report
07/11/202315:01BWXencor Reports Third Quarter 2023 Financial Results
03/11/202311:01BWXencor Presents Preclinical Data from Multiple XmAb®..
31/10/202315:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26/10/202307:11EDGAR2Form 8-K - Current report
26/10/202307:01BWXencor Announces Planned Retirement of Chief Financial..
27/9/202308:01BWXencor to Present Multiple Posters at the SITC Annual..
19/9/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:31EDGAR2Form 8-K - Current report
19/9/202315:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/9/202315:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
03/8/202316:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:02EDGAR2Form 8-K - Current report
03/8/202315:01BWXencor Reports Second Quarter 2023 Financial Results
27/7/202307:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03/7/202306:16EDGAR2Form 8-K - Current report
30/5/202317:01BWXencor Presents Clinical Results from Phase 1a Study of..
08/5/202315:01BWXencor Reports First Quarter 2023 Financial Results

Su Consulta Reciente

NASDAQ
XNCR
Xencor
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados